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Abstract: Unlike most other effector cells of the innate, as well as the adaptive immune systems, 
the neutrophil is a relatively undiscerning aggressor with scant regard for damage limitation. 
Although this highly combative, professional phagocyte has become increasingly implicated in 
the immunopathogenesis of many acute and chronic inﬂ  ammatory disorders, of both infective 
and noninfective origin, effective pharmacological strategies to counter neutrophil aggression 
have remained elusive. Activation of neutrophils results in rapid mobilization of both stored 
and extracellular Ca2+, resulting in abrupt, usually transient increases in cytosolic Ca2+, which 
precede, and are a prerequisite for activation of the Ca2+-dependent pro-inﬂ  ammatory activities 
of these cells. Mobilization of Ca2+ by, and restoration of Ca2+ homeostasis to activated neutro-
phils are multistep processes which present a number of potential targets, some well recognized 
and others novel and unconventional, for the pharmacological control of neutrophil-mediated 
inﬂ  ammation. Uncovering these targets represents the primary focus of this review.
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Introduction
Polymorphonuclear leukocytes, of which the neutrophil granulocyte is the most 
abundant, are key components of the innate immune system. These cells are activated 
and recruited to sites of infection by inﬂ  ammatory stimuli generated by microbial 
pathogens, or by the interaction of these with pattern recognition molecules present 
on/in neighboring tissue cells such as epithelial cells, mast cells and tissue macro-
phages. Notwithstanding their abruptly mobilizable arsenal of antimicrobial agents, 
which include antimicrobial peptides/proteins, enzymes, bioactive lipids, and reactive 
oxidant species (ROS) (Anderson et al 1998; Theron et al 2002; Hatanaka et al 2004), 
these cells also have biosynthetic capability, albeit limited (Cassatella 1999; Witko-
Sarsat et al 2000), which enables them to produce chemokines/cytokines, especially 
interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-α). Acting in concert, 
TNF-α and IL-8 amplify neutrophil-mediated inﬂ  ammatory responses by promoting 
extravasation and accumulation of neutrophils at sites of tissue injury and infection 
through induction and upregulation of expression of endothelial adhesion molecules 
and chemotaxis, respectively. Neutrophil migration and localization are further potenti-
ated by leukotriene B4 (LTB4), an endogenously generated bioactive lipid with potent 
chemoattractant activity (Chen et al 2006).
Although extremely effective in eradicating microbial pathogens, the neutrophil, 
with its arsenal of indiscriminate oxidants and proteases, poses a potential threat to 
bystander host cells and tissues in the vicinity of the inﬂ  ammatory reaction. Accord-
ingly, neutrophil inﬂ  ux must be efﬁ  cient, protective and promptly downregulated. 
Nevertheless, there is increasing awareness of the involvement of inappropriate Drug Design, Development and Therapy 2008:2 96
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activation of neutrophils in the etiology of many acute/hyper 
acute and chronic inﬂ  ammatory disorders of both infective 
and noninfective origin, important examples of which are 
shown in Figure 1, with the airways and cardiovascular 
system being particularly vulnerable.
Responsiveness to corticosteroids
Few currently available therapeutic agents, including corti-
costeroids, effectively control the harmful pro-inﬂ  ammatory 
activities of neutrophils. Indeed, insensitivity to corticoste-
roids appears to be a feature of those disorders in which the 
neutrophil is the predominant offender.
The apparent insensitivity of neutrophils is attributable to 
the coexistence of several different resistance mechanisms 
in these cells. Firstly, in contradistinction to other types of 
immune and inﬂ  ammatory cells, glucocorticoids delay neu-
trophil apoptosis. This antiapoptotic effect of glucocorticoids 
in neutrophils is achieved by a mechanism which involves 
sustained expression of the antiapoptotic Bcl-2 family pro-
tein, Mcl-1L (Sivertson et al 2007). Secondly, neutrophils 
contain high levels of the functionally inactive beta isoform 
of the glucocorticoid receptor (GR), the synthesis of which 
is further upregulated on exposure of the cells to IL-8 
(Strickland et al 2001), rendering them even less sensitive to 
corticosteroids. Although not yet described in neutrophils, the 
activity of the enzyme histone deacetylase, which is recruited 
by activated GRs as a mechanism of repression of expression 
of multiple inﬂ  ammatory genes, is decreased in macrophages 
and circulating mononuclear leukocytes of patients with 
COPD and severe asthma respectively (reviewed in Barnes 
2007). Thirdly, many of the proinﬂ  ammatory activities of 
neutrophils, including generation of ROS, release of granule 
proteases, and generation of prostanoids, eicosanoids, and 
platelet-activating factor (PAF) occur within seconds of 
receptor-mediated activation of these cells and are indepen-
dent of de novo protein synthesis.
Clearly the identiﬁ  cation of novel targets for effective 
neutrophil-directed anti-inﬂ  ammatory chemotherapy is a 
priority.
Calcium and neutrophils
Interaction of neutrophil membrane receptors with che-
moattractants, opsonized particles, or endothelial adhesion 
molecules, results in abrupt, transient increases in cytosolic 
Ca2+ which precede, and are a prerequisite, for initiation of 
the proinﬂ  ammatory activities of these cells. Ca2+-activatible 
inﬂ  ammatory functions include generation of superoxide by 
the membrane-associated electron transporting NADPH oxi-
dase, adhesion to vascular endothelium, degranulation, acti-
vation of cytosolic phospholipase A2 and 5-lipoxygenase, as 
well as synthesis of IL-8. Because of this critical dependence 
of activation of the proinﬂ  ammatory activities of neutrophils 
on Ca2+, the mechanisms utilized by these cells to mobilize 
and dispose of the cation represent attractive, and in several 
cases, novel potential targets for neutrophil-directed anti-
inﬂ  ammatory chemotherapy.
Calcium handling by activated neutrophils
A model of calcium mobilization and restoration of calcium 
homeostasis in activated human neutrophils is presented 
in Figure 2 and discussed below. Release of Ca2+ from 
intracellular stores following receptor-mediated activation of 
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Figure 1 Activation of neutrophils by chemoattractants such as FMLP, PAF, C5a, and LTB4 increases cytosolic Ca2+ concentrations with resultant generation of toxic reactive 
oxygen species (ROS) and release of proteases, matrix metalloproteinases (MMPs) and lipid mediators. The tissue injury that may be associated with release of these harmful 
molecules into the vicinity of innocent bystander host tissues contributes to the pathogenesis of numerous diseases, including chronic obstructive pulmonary disease (COPD) 
and the acute respiratory distress syndrome (ARDS).
Abbreviations: FMLP, N-formylated peptides/polypeptides; LTB4, leukotriene B4; PAF, platelet-activating factor.Drug Design, Development and Therapy 2008:2 97
Control of neutrophil-mediated inﬂ  ammation
FMLP, PAF
LTB 4, C5a Stimulus
GPCR
PLC
NADPH
Oxidase
PKC
DAG
IP3
ROS
Membrane
Depolarization
Ca2+ Ca2+
Membrane
Repolarization
IP3R
Autocrine
Loop
LTB 4
LTB 4
Ca2+
P
L
C
Ca2+
SOCC Ca2+ ATPase
Ca2+  ATPase
Na+/Ca2+
ROS
cPLA2
AA
5-LO
PKA +
_
+ _
Figure 2 Calcium-mobilizing stimuli interact with membrane G-protein coupled receptors (GPCR) to activate phospholipase C (PLC) generating inositol triphosphate (IP3) 
which interacts with IP3 receptors (IP3R) releasing Ca2+ from storage vesicles. Cytosolic Ca2+ activates cytosolic phospholipase A2 (cPLA2) which mobilizes arachidonic acid 
(AA) for the 5-lipoxygenase (5-LO) pathway.   The AA metabolite leukotriene B4 (LTB4) is actively transported to the cell exterior where it binds to its receptor to activate PLC, 
completing a positive feedback autocrine loop. Ca2+ released into the cytosol is rapidly extruded from the cell by the plasma membrane Ca2+ ATPase and resequestered into 
storage vesicles by the protein kinase A (PKA)-sensitive endomembrane Ca2+ ATPase. Protein kinase C (PKC) activated by Ca2+ and diacylglycerol (DAG) facilitates assembly 
and activation of NADPH oxidase on the outer membrane which generates reactive oxygen species (ROS) with concomitant membrane depolarization. The depolarized 
membrane potential delays Ca2+ entry through store operated channels (SOCCs) until the Ca2+-activatible Na+/Ca2+ exchanger, operating in reverse mode, mediates recovery 
of the membrane potential promoting Ca2+ reuptake via SOCCs. PKC down-regulates PLC as part of a negative feedback loop to terminate IP3 production.
neutrophils with various stimuli, including chemoattractants 
such as N-formylated peptides/polypeptides (FMLP), C5a, 
leukotriene B4 (LTB4), PAF, or IL-8, occurs rapidly, reaching 
peak values within several seconds of ligand-receptor binding 
which are 5–10-fold above the basal value of about 100 nM 
(Favre et al 1996). The receptors for the aforementioned 
chemoattractants belong to the 7-transmembrane, 
G-protein-coupled family of receptors. Occupation of 
these receptors, which are regulated by various Gα and 
Gβγ   subunits, results in activation of the β isoforms of Drug Design, Development and Therapy 2008:2 98
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phospholipase C (PLC), which in turn mediate production of 
inositol-1,4,5-triphosphate (IP3) by hydrolysis of phosphati-
dylinositol-4,5,-biphosphate (Ali et al 1998; Yue et al 1998). 
IP3 interacts with Ca2+-mobilizing receptors on intracellular 
storage vesicles, resulting in discharge of stored Ca2+ into the 
cytosol. Only modest increases in IP3 of around 15% of maxi-
mal are required to mobilize the total pool of stored Ca2+. The 
duration of the peak increase in cytosolic Ca2+ varies according 
to the type and concentration of the chemoattractant, but is 
usually brief, being followed by a progressive decline in the 
concentration of cytosolic Ca2+ with a return to basal values 
within several minutes. The duration of the peak cytosolic Ca2+ 
response, as well as the rate of decline in the concentration of 
cytosolic Ca2+, are determined by at least 4 mechanisms. These 
are: i) shuttling of Ca2+ between the stores and the cytosol (ie, 
repetitive bouts of release from, and resequestration of Ca2+ 
into stores (Anderson et al 2005); ii) activation of a secondary 
wave of Ca2+ inﬂ  ux due to endogenously-generated LTB4 by 
chemoattractant-activated neutrophils (Steel et al 2007); iii) 
the efﬁ  ciency of the systems which promote clearance of Ca2+ 
from the cytosol (Anderson et al 1998; Steel and Anderson 
2002); and iv) the efﬁ  ciency of the systems which regulate 
the time of onset, rate and magnitude of inﬂ  ux of extracellular 
cation (Tintinger et al 2001a).
Restoration of Ca2+ homeostasis
Rapid and efﬁ  cient removal of Ca2+ from the cytosol of 
activated neutrophils ensures that activation of the cells is 
brief, thereby avoiding Ca2+ overload and hyperreactivity. 
This is achieved primarily by removal of Ca2+ from the 
cytosol by two adenosine triphosphate (ATP)-driven Ca2+ 
pumps operating in unison. These are the plasma membrane 
Ca2+-ATPase and the endomembrane Ca2+-ATPase, which 
mediate Ca2+ efﬂ  ux and resequestration respectively. These 
two Ca2+ pumps appear to contribute equally to the removal 
of Ca2+ from the cytosol of activated neutrophils (Anderson 
and Goolam Mahomed 1997; Pettit and Hallett 2000).
The plasma membrane Ca2+-ATPase of neutrophils 
is upregulated by calmodulin, acidic phospholipids, and 
polyunsaturated fatty acids, all of which shift the pump to 
a higher afﬁ  nity for Ca2+, resulting in enhanced maximal 
velocity (Carafoli et al 1992).
Apart from causing activation of PLC and release 
of stored Ca2+, activation of neutrophils with chemoat-
tractants such as FMLP is also accompanied by transient 
activation of adenylate cyclase (Iannone et al 1989; 
Theron et al 2002).This results from the interaction of 
adenosine, generated by dephosphorylation of adenylates, 
presumably by ecto-5’nucleotidase, with G-protein/
adenylyl cyclase-coupled adenosine receptors (AR) of the 
A2A subtype on the neutrophil membrane (Iannone et al 
1989; Theron et al 2002), resulting in activation of adenos-
ine 3’,5’-cyclic monophosphate (cAMP)-dependent protein 
kinase A (PKA). Phospholamban, a polypeptide regulator of 
the endomembrane Ca2+-ATPase, undergoes PKA-mediated 
phosphorylation which results in up-regulation of the Ca2+ 
sequestering/resequestering activity of the pump (Chu 
et al 2000).
Importantly, efﬁ  cient clearance of Ca2+ by the plasma 
membrane and endomembrane Ca2+-ATPases is facilitated by 
the membrane depolarizing action of NADPH oxidase which 
restricts the inﬂ  ux of extracellular Ca2+. NADPH oxidase 
undergoes Ca2+-dependent activation on exposure of neu-
trophils to chemoattractants such as C5a, FMLP, and LTB4, 
but not PAF or IL-8 (Steel and Anderson 2002; Guichard 
et al 2007), as well as to opsonized antigens. Activation of 
NADPH oxidase is accompanied by an abrupt and steep 
decrease in membrane potential which results primarily from 
the electrogenic properties of the oxidase (Tintinger et al 
2001a). When the cells are depolarized, the driving force for 
entry of Ca2+ is abolished because the electrical component 
of the electrochemical gradient promoting Ca2+ entry is 
markedly reduced. Consequently, NADPH oxidase-mediated 
membrane depolarization enables the plasma membrane and 
endomembrane Ca2+-ATPases to mediate clearance of Ca2+ 
from the cytosol of activated neutrophils, unhindered by 
inﬂ  ux of extracellular Ca2+.
Inﬂ  ux of Ca2+
Depletion of intracellular Ca2+ stores following receptor-
mediated activation is followed by reﬁ  lling of the stores, a 
process known as store-operated Ca2+ inﬂ  ux, or capacitative Ca2+ 
inﬂ  ux (Parekh and Penner 1997). In neutrophils, the time of 
onset and rate of store-operated Ca+ inﬂ  ux are determined 
primarily by the duration and intensity of activity of NADPH 
oxidase. In the case of cells activated with Ca2+-mobilizing 
stimuli which are inefﬁ  cient activators of the oxidase, such 
as PAF (Steel and Anderson 2002), inﬂ  ux of Ca2+ occurs 
rapidly, overwhelming the Ca2+-ATPases, resulting in pro-
longed elevations in peak cytosolic Ca2+ concentrations. 
On the other hand, exposure of the cells to Ca2+-mobilizing 
activators of the oxidase, such as FMLP, is accompanied 
by efﬁ  cient clearance of store-derived cytosolic Ca2+, in the 
setting of a gradual inﬂ  ux of Ca2+, the rate of which is super-
imposable on that of membrane repolarization (Tintinger and 
Anderson 2004).Drug Design, Development and Therapy 2008:2 99
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While the magnitude and duration of the maximal 
membrane depolarization responses of neutrophils activated 
with FMLP are determined by the intensity and duration of 
activation of NADPH oxidase, as well as by the counteract-
ing effects of an efﬂ  ux of protons from the cells (Schrenzel 
et al 1998; Bánﬁ   et al 2000), until relatively recently less was 
known about the mechanisms which contribute to membrane 
repolarization. We have identiﬁ  ed a role for the electrogenic 
Na+/Ca2+ exchanger operating in reverse mode in mediating 
membrane repolarization in activated neutrophils (Tintinger 
and Anderson 2004).
As opposed to being a major transporter of extracellular 
Ca2+ for store reﬁ  lling, the primary role of the exchanger 
when operating in reverse mode is to mediate recovery of 
the membrane potential which is necessary to drive the inﬂ  ux 
of Ca2+ through store-operated Ca2+ channels (Tintinger 
and Anderson 2004). However, the Na+/Ca2+ exchanger 
is vulnerable to oxidative inactivation, being sensitive to 
the phagocyte-derived oxidants, hydrogen peroxide, and 
especially hypochlorous acid (Coetzee et al 1994; Tintinger 
et al 2007). The efﬁ  ciency of the exchanger in activated 
neutrophils is therefore dependent on its level of exposure 
to phagocyte-derived oxidants.
Store-operated Ca2+ channels
Until very recently, the precise molecular identity of the 
store-operated Ca2+ channels operative in human neutrophils 
and other cell types had not been conclusively established. 
One particular family of nonvoltage-activated Ca2+ channels 
which had attracted considerable attention and interest was 
the family of transient receptor potential (TRP) channels 
(Elliot 2001; Li et al 2002). Although two members of this 
family, LTFP2 and TRP6, have been described in neutro-
phils (Li et al 2002; Heiner et al 2003), the characteristics 
of these channels are not entirely compatible with those of 
putative, prototype store-operated Ca2+ channels. However, 
in the past two years the identities of the major components 
of store-operated Ca2+ channels have been elucidated. These 
are the proteins Stim1 (and possibly Stim2), and Orai1 (and 
possibly Orai2 and 3), which function as the Ca2+ sensing 
and channel-forming proteins, respectively (Spassova et al 
2006). Stim1 is located in the endoplasmic reticulum where 
it binds reversibly to Ca2+. Following store depletion, disso-
ciation of Ca2+ causes Stim1 to redistribute within the endo-
plasmic reticulum to areas which are in close proximity to 
Orai1 within the plasma membrane. Stim1 then activates the 
Ca2+-selective Orai channels by a mechanism which remains 
to be elucidated (reviewed by Putney 2007).
Neutrophil-directed anti-inﬂ  ammatory 
strategies
Notwithstanding the increasing awareness of the anti-
inﬂ  ammatory potential of macrolide antimicrobial agents 
(Simpson et al 2008), several other categories of anti-
inﬂ  ammatory agents have recently been described which have 
the potential to target neutrophils. These agents, described 
in detail elsewhere (Barnes 2007), include: i) antagonists of 
receptors for chemoattractants such as C5a, IL-8, and LTB4; 
ii) antagonists of endothelial adhesion molecules; iii) inhibitors 
of pro-inﬂ  ammatory enzymes and transcription factors such 
as phosphoinositide 3-kinase, 38 mitogen-activated protein 
kinase, and nuclear factor kappa B; and iv) activators of histone 
deacetylase 2 which is recruited by activated glucocorticoid 
receptors to switch off multiple proinﬂ  ammatory genes.
In addition to these, recent insights into the mechanisms 
utilized by activated neutrophils to mobilize both intra-
cellular and extracellular Ca2+, as well as to restore Ca2+ 
homeostasis to the cells present a number of novel targets 
which are amenable to pharmacological control. In some 
cases target enhancement of activity improves the efﬁ  ciency 
of clearance of Ca2+ from the cytosol, while in others this is 
achieved by target inhibition. Targets in the former category 
include endomembrane Ca2+ ATP-ases, NADPH oxidase, 
myeloperoxidase, and protein kinase C, while in the lat-
ter category, phospholipase C, the Na2+/Ca2+ exchanger, 
5’-lipoxygenase, and store-operated Ca2+ channels represent 
attractive targets.
Ca2+ mobilization and restoration 
of Ca2+ homeostasis as targets 
for neutrophil-directed anti-
inﬂ  ammatory chemotherapy
Inhibitors of phospholipase C
The importance of PLC as a potential target is underscored 
by the critical involvement of IP3, not only in mediating the 
release of Ca2+ from intracellular stores, but also in sustain-
ing elevations in cytosolic Ca2+ by promoting shuttling of 
the cation between the stores and the cytosol (Anderson 
et al 2005) and possibly by initiating inﬂ  ux of Ca2+ (Ma 
2000; Bolotina 2004). Furthermore, diacylglycerol (DAG) 
generated by PLC activates protein kinase C (PKC), which 
in turn promotes the assembly and activation of NADPH 
oxidase (Tauber 1987).
Although pharmacological inhibitors of PLC and 
antagonists of IP3 receptors such as U73122 and 
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in experimental systems, no such inhibitors are available for 
clinical use. However, PLC activity is inhibited in various 
cell types such as vascular endothelial cells (Avdonin and 
Ryan 2000) and platelets (Murphy et al 1991) by a negative 
feedback loop involving PKC. This feedback inhibition on 
PLC by PKC appears to be operative in human neutrophils 
as we have demonstrated recently that in the presence of 
PKC inhibitors, such as GF109203X, IP3, and cytosolic Ca2+ 
concentrations in chemoattractant-activated neutrophils reach 
higher peaks and remain elevated longer than those measured 
in untreated cells (unpublished observations). This ﬁ  nding 
is important as it provides insight into the physiological 
mechanisms that down-regulate PLC in activated neutro-
phils and has implications for the design of pharmacological 
strategies targeting PKC, as inhibitors of this enzyme may 
paradoxically enhance the Ca2+-dependent proinﬂ  ammatory 
activities of phagocytes. In contradistinction to the paucity of 
clinically useful PLC or PKC inhibitors, the endomembrane 
Ca2+ ATPase is considerably more amenable to pharmaco-
logic interventions.
Upregulation of endomembrane
Ca2+ ATP-ases
The activity of the Ca2+ resequestering endomembrane Ca2+ 
ATP-ases can be upregulated by the cAMP-sensitive enzyme, 
protein kinase A (PKA) (Chu et al 2000). PKA-mediated 
enhancement of the activity of the endomembrane Ca2+ 
ATP-ase markedly accelerates the clearance of cytosolic Ca2+ 
following release of the cation from storage vesicles (Anderson 
et al 1998; Tintinger et al 2001b). The apparent sensitivity of 
PKA to cAMP has been exploited with the introduction of a 
wide range of pharmacologic agents, all of which share the 
ability to elevate intracellular cAMP concentrations. This can 
be achieved by several mechanisms, including activation of 
adenylate cyclase, or inhibition of phosphodiesterase enzymes 
(PDEs) responsible for the metabolism of cAMP (Moore 
and Willoughby 1995). Adenylate cyclase is activated via 
G-protein-coupled receptors linked to membrane associated 
β-adrenergic, adenosine (A2A) and prostaglandin E2 receptors. 
PDE isoenzymes of various classes have been identiﬁ  ed in 
neutrophils and PDE 4B2 is probably the most abundant of 
these (Wang et al 1999). The relative tissue speciﬁ  city of 
PDE 4 isoenzymes for inﬂ  ammatory cells has enabled some 
degree of pharmacological targeting of neutrophils by new 
generation agents such as roﬂ  imulast (Sanz et al 2007) and 
cilomilast (Baumer et al 2007).
The validity of this pharmacologic approach has been 
conﬁ  rmed in vitro as cAMP-elevating agents markedly 
suppress a range of Ca2+-dependent proinflammatory 
activities of neutrophils, including adhesion to vascular 
endothelium (Bloemen et al 1997), oxidant production 
(Tintinger et al 2000), as well as release of proteases, 
eicosanoids, and cytokines (Moore and Willoughby 1995; 
Tintinger et al 2000). Furthermore, numerous clinical trials 
are ongoing or have been completed in which the efﬁ  cacy of 
these agents has been veriﬁ  ed in vivo (Pauwels et al 1997; 
Sullivan et al 2001; Vignola 2004). Less well documented, 
however, is the role of cGMP during the restoration of Ca2+ 
homeostasis in activated neutrophils. Intracellular cGMP 
concentrations can be increased by activation of guanylate 
cyclase, or by inhibition of PDEs that metabolize cGMP, 
predominantly PDEs 3 and 5 (Torphy 1998). The endomem-
brane Ca2+-ATPase has been identiﬁ  ed as a putative target of 
cGMP acting via protein kinase G (Ay et al 2006), although 
other mechanisms may exist whereby cGMP accelerates 
the clearance of cytosolic Ca2+. In this regard, cGMP may 
elevate intracellular cAMP levels by effectively acting as 
a competitive antagonist of PDE 3-mediated hydrolysis of 
cAMP (PDE 3 hydrolyzes both cyclic nucleotides) (Boswell-
Smith et al 2006). The selective PDE 3 inhibitor, cilostazol, 
signiﬁ  cantly attenuated FMLP-mediated adhesion of neu-
trophils to human umbilical endothelial cells in vitro (Yang 
et al 2006), and suppressed the cough threshold in elderly 
asthmatics (Ishiura et al 2005).
Inhibitors of 5-Lipoxygenase
Leukotrienes, such as LTB4, are produced by activated neu-
trophils consequent to upregulation of the 5-lipoxygenase 
(5-LO) pathway (Peters-Golden and Henderson 2007). 
Phospholipase A2 hydrolyzes membrane phospholipids lib-
erating arachidonic acid, the substrate for 5-LO, and in the 
presence of calcium and 5-lipoxygenase-activating protein 
(FLAP), activated 5-LO generates leukotriene A4, which in 
neutrophils is converted to LTB4. The diverse role of LTB4 
in promoting inﬂ  ammation includes recruitment of inﬂ  am-
matory cells (De Caterina and Zampolli 2004), activation 
of cytosolic PLA2 and degranulation (Boyce 2007), as well 
as the release of cytokines and matrix metalloproteinases, 
thus playing a role in immunoregulation (Rola-Pleszczynki 
et al 1986; Ford-Hutchinson 1990; Leppert et al 1995). In 
addition to the physiological responses above, LTB4 also 
participates in a positive feedback autocrine loop which 
activates phospholipase C and triggers sustained elevations 
of cytosolic Ca2+ in PAF-activated neutrophils (McDonald 
et al 1994; Steel et al 2007). Intracellular LTB4 derived 
from 5-LO is actively transported to the cell exterior where Drug Design, Development and Therapy 2008:2 101
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it interacts with high afﬁ  nity LTB4 receptors (BLT1) linked 
to PLC on the neutrophil plasma membrane. This interaction 
induces a secondary pulse of IP3 which mediates sustained 
release of Ca2+ into the cytosol and this in turn potentiates 
Ca2+-dependent pro-inﬂ  ammatory responses (Surette et al 
1999; Steel et al 2007).The validity of pharmacological 
anti-inﬂ  ammatory strategies targeting LTB4 is underscored 
by recent evidence for the involvement of this leukotriene 
in the pathogenesis of bronchial asthma (De Caterina and 
Zampolli 2004), COPD (Marian et al 2006), and inﬂ  amma-
tory arthritis (Chen et al 2006). Importantly, the imidazole 
antimycotic, itraconazole, antagonizes the effects of LTB4 
in PAF-activated neutrophils by inhibiting 5-LO (Steel 
et al 2007). The concentrations of itraconazole required to 
inhibit 5-LO are similar to those achieved in the plasma of 
patients receiving this antimycotic (Kageyama et al 1999). 
Interestingly, other agents in this class, ﬂ  uconazole and ﬂ  u-
trimazole, may also possess anti-inﬂ  ammatory properties as 
the former decreased mortality in critically ill patients by a 
mechanism unrelated to its antifungal properties (Jacobs et al 
2003), while the latter inhibited arachidonic acid-induced ear 
edema in a murine model (Merlos et al 1996). Other 5-LO 
inhibitors such as zileuton, which inhibits production of 
both LTB4 and the cysteinyl leukotrienes, LTC4 and LTD4, 
by activated eosinophils, have shown efﬁ  cacy in clinical 
trials of patients with bronchial asthma (Peters-Golden and 
Henderson 2007).
This is in keeping with the well established pathogenetic 
role of cysteinyl leukotrienes in inﬂ  ammatory airway diseases 
(Arm 2004), and although neutrophils do not generate LTC4, 
or LTD4, receptors for cysteinyl leukotrienes, namely CysLT1 
and CysLT2 are present on the plasma membrane of these 
cells. The physiological signiﬁ  cance of these receptors is 
unknown, but we have found recently that cysteinyl leukot-
rienes act as receptor-mediated priming agents for human 
neutrophils in vitro. Pretreatment of neutrophils with these 
agents augments the subsequent responses to FMLP with 
marked increases in oxidant production and elastase release 
compared with cells activated with the chemoattractant alone 
(unpublished observations). This ﬁ  nding is likely to be of 
importance given the widespread use of CysLT1 receptor 
antagonists such as montelukast, pranlukast and zaﬁ  rlukast, 
all of which may modulate cysteinyl leukotriene-mediated 
priming of neutrophils in a clinical setting.
NADPH oxidase
The membrane-associated NADPH oxidase complex 
is assembled on the plasma membrane and becomes 
incorporated into the phagocytic vacuole following phago-
cytosis of microbial pathogens. When activated, the oxidase 
generates highly ROS by transferring electrons from NADPH 
to molecular oxygen. This electrogenic transfer of electrons 
results in signiﬁ  cant depolarization of the resting membrane 
potential. The oxygen radicals formed during this process 
include superoxide anions, hydroxyl radicals, hydrogen 
peroxide and hypochlorous acid (Nagata 2005), all of which 
may participate in the killing of microbial pathogens. How-
ever, these toxic molecules have also been implicated in the 
pathogenesis of numerous diseases as their release to the 
extracellular environment may damage innocent bystander 
host tissues (Moraes et al 2006). Although inhibition of the 
oxidase may abolish the generation of toxic ROS, this also 
abrogates the membrane depolarization response and dis-
sipates the electrical gradient required to restrain Ca2+ entry 
into leukocytes. Veritably, neutrophils lacking a functional 
oxidase such as those of patients with chronic granulomatous 
disease (CGD), are inherently predisposed to Ca2+ overload 
(Tintinger et al 2001a; Rada et al 2003) with consequent exag-
geration of Ca2+-dependent proinﬂ  ammatory activity, includ-
ing increased release of proteolytic enzymes (Tintinger et al 
2001a) and cytokines (Bylund et al 2007). NADPH oxidase 
thus fulﬁ  lls dual roles as destroyer of microbial pathogens 
and in protecting the cell from Ca2+ ﬂ  ooding of the cytosol 
mediated by its important membrane depolarizing action. 
Therefore, somewhat paradoxically, enhancing the activity 
of the oxidase may uncover unforeseen anti-inﬂ  ammatory 
properties (Hallett 2003; Hultqvist et al 2006).
In addition to mediating membrane depolarization, recent 
evidence suggests that the oxidase also indirectly modulates 
the rate of neutrophil membrane repolarization (Tintinger 
et al 2007). In this regard, myeloperoxidase (MPO) and 
hypochlorous acid have emerged as important regulators of 
the neutrophil membrane potential following activation of 
NADPH oxidase.
Myeloperoxidase and
hypochlorous acid
Myeloperoxidase is stored in tertiary granules in the neu-
trophil cytosol and following the formation of phagocytic 
vacuoles is released into the phagosome, together with 
ROS generated from the concomitant activation of NADPH 
oxidase. Hydrogen peroxide thus formed acts as a substrate 
for MPO which catalyzes its conversion to the highly reac-
tive oxidant, hypochlorous acid (HOCl). In the presence of 
MPO inhibitors such as sodium azide or 4-aminobenzoyl 
hydrazide (ABAH), the magnitude of neutrophil membrane Drug Design, Development and Therapy 2008:2 102
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depolarization in response to activating stimuli such as FMLP 
is not altered. However, the rate of recovery of the membrane 
potential is signiﬁ  cantly accelerated (Tintinger et al 2007) 
and this is associated with an increased rate and magnitude of 
Ca2+ reuptake. Thus, inhibition of HOCl generation promotes 
rapid recovery of the membrane potential and accelerates 
the rate of capacitative Ca2+ entry, underscoring the regula-
tory roles of MPO and HOCl during these events. This may 
paradoxically represent a physiological anti-inﬂ  ammatory 
activity of HOCl given the calcium requirements of numer-
ous pro-inﬂ  ammatory neutrophil functions. Lending support 
to this contention, exaggerated inﬂ  ammatory responses have 
been observed in the skin and lungs of MPO-deﬁ  cient mice 
exposed to injurious ultraviolet light and irradiation, respec-
tively (Milla et al 2004; Komatsu et al 2006).
Inhibition of store-operated calcium 
channels
The IP3-mediated release of Ca2+ from neutrophil storage 
vesicles is associated with activation of Ca2+ entry channels 
on the plasma membrane of these cells in order to facilitate 
store reﬁ  lling. The mechanism of activation of these store-
operated channels (SOCCs) remains controversial, although 
recent evidence suggests a role for proteins Stim 1 and Orai 1 
(Spassova et al 2006). Given the elusive nature of the struc-
ture and mechanism/s of activation of these channels, it has 
been difﬁ  cult to design pharmacologic inhibitors of SOCCs. 
However, the recent advances in our understanding of these 
channels, notably Stim 1 and Orai 1 (Putney 2007), may 
pave the way for the development of agents that antagonize 
this mechanism of Ca2+ reuptake. Regardless of the precise 
identity of, or coupling mechanisms that activate SOCCs, 
the rate of Ca2+ entry through these channels is regulated 
by the electrochemical gradient for Ca2+ across the plasma 
membrane (Geiszt et al 1997). Accordingly, at depolarized 
potentials, Ca2+ reuptake is opposed by the electrical gradient 
and is only initiated during the recovery phase of the mem-
brane potential. Crucially, the rate of membrane repolariza-
tion is modulated by the activity of the plasma membrane 
Na+/Ca2+ exchanger.
Inhibition of the Na+/Ca2+ exchanger
The reverse mode of the Na+/Ca2+ exchanger is activated 
by the rapid rise in cytosolic Ca2+ consequent to release of 
the cation from stores. When operating in reverse mode, the 
exchanger extrudes 3 Na+ ions for each Ca2+ ion entering the 
cell (Blaustein and Lederer 1999), with a resultant net loss of 
positive charge. Although proton efﬂ  ux from the cell is the 
primary charge compensating mechanism (Schrenzel et al 
1998; Bánﬁ   et al 1999), the electrogenic Na+/Ca2+ exchanger 
contributes to recovery of the membrane potential (Tintinger 
and Anderson 2004) and represents a target amenable to phar-
macologic intervention. Inhibitors of the reverse mode of the 
Na+/Ca2+ exchanger such as KB-R7943 markedly retard the 
rate of membrane repolarization with consequent attenuation of 
the rate and magnitude of Ca2+ reuptake (Tintinger and Ander-
son 2004). It is likely that delayed Ca2+ entry with incomplete 
reﬁ  lling of Ca2+ storage vesicles mediated by inhibitors of the 
exchanger may down-regulate the proinﬂ  ammatory activity 
of neutrophils. Agents that inhibit the reverse mode of the 
Na+/Ca2+ exchanger including KB-R7943 and SN-6 have 
shown promise in animal models of ischemia-reperfusion 
injury (Iwamato 2007), a condition in which activated neutro-
phils are considered to play a central pathogenetic role (Buras 
and Reenstra 2007). Interestingly, the expression of Na+/Ca2+ 
exchanger genes is upregulated in leukocytes from patients 
with cardiac failure (Seiler et al 2004).
Conclusions
Advances in our understanding of the physiologic mechanisms 
pertaining to calcium handling by activated neutrophils have 
facilitated recognition of novel pharmacologic strategies 
designed to suppress the pro-inﬂ  ammatory activities of these 
cells. The distinct potential for agents such as imidazole anti-
mycotics, antagonists of cysteinyl leukotriene receptors, inhibi-
tors of the Na+/Ca2+ exchanger, long-acting beta-adrenergic 
receptor agonists and phosphodiesterase inhibitors to modulate 
neutrophil-mediated inﬂ  ammation in vivo, creates exciting new 
opportunities for researchers in this important ﬁ  eld.
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